Effect of interleukin 13 on bronchial hyperresponsiveness and the bronchoprotective effect of β-adrenergic bronchodilators and corticosteroids

Annals of Allergy, Asthma and Immunology

Volumn 102, Issue 3, 2009, Pages 190-197

  Townley, Robert G ^a   Gendapodi, Pradeep R ^a   Qutna, Nidal ^a   Evans, Joseph ^a   Romero, Francisco A ^a   Abel, Peter ^b  

^a CREIGHTON UNIVERSITY   (United States)

^b CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUTICASONE; HYBRID PROTEIN; IMMUNOGLOBULIN FC FRAGMENT; INTERLEUKIN 13; INTERLEUKIN 13 RECEPTOR ALPHA2; INTERLEUKIN 13 RECEPTOR ALPHA2 IMMUNOGLOBULIN FC FRAGMENT FUSION PROTEIN; METHACHOLINE; OVALBUMIN; SALBUTAMOL; SALMETEROL; UNCLASSIFIED DRUG;

ANIMAL MODEL; ARTICLE; BAGG ALBINO MOUSE; BRONCHODILATATION; BRONCHUS HYPERREACTIVITY; CONTROLLED STUDY; DRUG EFFECT; EXPIRED AIR; FEMALE; MALE; MOUSE; NEBULIZATION; NONHUMAN; PRIORITY JOURNAL; PROTECTION; PROVOCATION TEST; SKIN SENSITIZATION; TREATMENT RESPONSE;

EID: 63449125724     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)60080-4     Document Type: Article

References (48)

1. 2"aclrenoceptor responsiveness and asthma activity. Clin Exp Allergy. 1998;28:257-260.
2. Bai TR, Mark JCW, Barnes PJ. A comparison of β-adrenergic receptors and in vitro relaxant responses to isoproterenol in asthmatic airway smooth muscle. Am J Respir Cell Mol Biol. 1992;6:647-651.
3. 2-adrenergic receptor on the response to regular use of albuterol in asthma. Am J Respir Crit Care Med. 2000;162:75-80.
4. Shore S, Moore PE. Effects of cytokines on contractual and dialator responses of airway smooth muscle. Clin Exp Pharmacol Physiol. 2002;
5. 29:859-866.
6. Lim S, Jatakanon A, John M, et al. Effect of inhaled budesonide on lung function and airway inflammation: assessment by various inflammatory markers in mild asthma. Am J Respir Med. 1999;159:22-30.
7. Meagher LC, Cousin JM, Seckl JR, Haslett C. Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes. J Immunol. 1996;156:4422-4428.
8. Mano K, Akbarzadeh A, Townley RG. Effect of hydrocortisone on β-adrenergic receptors in lung membranes. Life Sci. 1979;25: 1925-1930.
9. Hirst SJ, Lee TH. Airway smooth muscle as a target of glucocorticoid action in the treatment of asthma. Am J Respir Crit Care Med. 1998; 158:S201-S206.
10. Mak JCW, Nishikawa M, Barnes PJ. Glucocorticosteroids increase beta;-adrenergic receptor transcription in human lung. Am J Physiol Lung Cell Mol Physiol. 1995;268:L41-L46.
11. Tan KS, Grove A, McLean A, Gnosspelius Y, Hall IP, Lipworth BJ. Systemic corticosteroid rapidly reverses bronchodilator subsensitivity induced by formoterol in asthmatic patients. Am J Respir Crit Care Med. 1997;156:28 -35.
12. Hayes MJ, Qing F, Rhodes CG, et al. In vivo quantification of human pulmonary beta;-adrenoceptors: effect of beta;-agonist therapy. Am J Respir Crit Care Med. 1996;154:1277-1283.
13. Nijkamp FP, Engels F, Henricks PAJ, Van Oosterhout AJM. Mechanism of beta;-adrenergic receptor regulation in lungs and its implication for physiological responses. Physiol Rev. 1992;72:323-367.
14. 2-bronchodilators. Eur J Clin Pharmacol. 1998;34:145-150.
15. Hui KKP, Connolly ME, Taskin DP. Reversal of human lymphocyte beta;-adrenoceptor desensitization by glucocorticoids. Clin Pharmacol Ther. 1982;32:566-571.
16. Wills-Karp M, Luimbazi J, Xu X, et al. Interleukin-13: central mediator of allergic asthma. Science. 1998;282:2258 -2261.
17. Kuperman DA, Huang X, Koth LL, et al. Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma. Nat Med. 2002;8:885-889.
18. Townley R, Horiba M. Airway hyperresponsiveness: a story of mice and men and cytokines. Clin Rev Allergy Immunol. 2003;24:85-110.
19. Townley RG. IL-13 and the beta;-adrenergic blockade theory of asthma revisited 40 years later. Ann Allergy Asthma Immunol,. 2007;99: 215-224.
20. Grunig G, Warnock M, Wakil AE, et al. Requirement for IL-13 independently of IL-4 in experimental asthma. Science. 1998;282: 2261-2263.
21. Wills-Karp M. Interleukin-13 in asthma pathogenesis. Immunol Rev. 2004;202:175-190.
22. Matsukura S, Stellato C, Georas SN, Casolaro V, Plitt JR, Miura K. Interleukin-13 upregulates eotaxin expression in airway epithelial cells by a stat6-dependent mechanism. Am J Respir Cell Mol Biol. 2001;24: 755-761.
23. Li L, Xia Y, Nguyen A, Lai YH, Feng L, Mosmann TR. Effects of Th2 cytokines on chemokine expression in the lung: IL-13 potently induces eotaxin expression by airway epithelial cells. J Immunol. 1999;162: 2477-2487.
24. Grunstein MM, Hakonarson H, Leiter J, et al. IL-13-dependent autocrine signaling mediates altered responsiveness of IgE-sensitized airway smooth muscle. Am J Physiol Lung Cell Mol Physiol. 2002;282: L520-L528.
25. Townley RB, Gendapodi, PR, Evans J, Romero FA. Effects of fluticasone and/or beta;-agonist on airway hyperresponsiveness (AHR) in mice either sensitized to allergen or pre-treated with IL-13 [abstract]. J Allergy Clin Immunol. 2007;119:S295.
26. Horvath G, Mendes E, Schmid N, et al. The effect of corticosteroids on the disposal of long-acting beta;-2 agonists by airway smooth muscle cells. J Allergy Clin Immunol. 2007;120:1103-1109.
27. Ketchell R, Jensen M, Lumley P, Wright A, Allenby M, O'Connor B. Rapid effect of inhaled fluticasone propionate on airway responsiveness to adenosine 5'-monophosphate in mild asthma. J Allergy Clin Immunol. 2002;10:603-606.
28. Rodrigo GT. Rapid effect of inhaled corticosteroids in acute asthma: an evidence-based evaluation. Chest. 2006;130:1301-1311.
29. Rodrigo G, Rodrigo, C. Inhaled flunisolide for acute severe asthma. Am J Respir Crit Care Med. 1998;157:698-703.
30. Norman AW, Mizwicki MT, Norman DPG. Steroid-hormone rapid actions, membrane receptors and a conformational ensemble model. Nat Rev Drug Discov. 2004;3:27-41.
31. Ma B, Liu W, Homer RJ, et al. Role of CCR5 in the pathogenesis of IL-13-induced inflammation and remodeling; J Immunol 2006;176: 4968-4978.
32. Fushimi T, Okayama H, Shimura S, Saitoh H, Shirato K. Dexametha-sone suppresses gene expression and production of IL-13 by human mast cell line and lung mast cells. J Allergy Clin Immunol. 1998;102: 134-142.
33. Braun CM, Huang SK, Bashian GG, Kabey-Sobotka A, Lichtenstein LM, Essayan DM. Corticosteroid modulation of human, antigen-specific Th1 and Th2 responses. J Allergy Clin Immunol. 1997;100:400- 407.
34. Kibe A, Inoue H, Fukyama S, et al. Differential regulation by glucocorticoid of interleukin-13-induced eosinophilia, hyperresponsiveness, and goblet cell hyperplasia in mouse airways. Am J Respir Crit Care Med. 2003;167:50-56.
35. Townley RG. Adrenergic receptors, mechanisms, and the late allergic reaction: therapeutic role of the new long-acting beta;-agonists. In: Townley RG, Agrawal DK, eds. Immunopharmacology of Allergic Diseases. New York, NY: Marcel Dekker, 1996:491-521.
36. Goleva E, Hauk PJ, Boguniewicz J, Martin RJ, Leung DYM. Airway remodeling and lack of bronchodilator response in steroid-resistant asthma. J Allergy Clin Immunol. 2007;120:1065-1072.
37. Deshpande DA, Dogan S, Walseth TF, et al. Modulation of calcium signaling by interleukin-13 in human airway smooth muscle: role of CD38/cyclic adenosine diphophosphate ribose pathway. Am J Respir Cell Mol Biol. 2003;31:36-42.
38. Hew M, Bhavsar P, Torrego A, et al; National Heart, Lung, and Blood Institute's Severe Asthma Research Program. Relative corticosteroid insensitivity of peripheral blood mononuclear cells in severe asthma. Am J Respir Crit Care Med. 2006;174:134-141.
39. Nasheer T, Minshall EM, Leung DYM, et al. Expression of IL-12 and IL-13 mRNA in asthma and their modulation in response to steroid therapy. Am J Respir Crit Care Med. 1997;55:845-851.
40. Leung DYM, Martin RJ, Szefler SJ, et al. Disregulation of interleukin-4, interleukin-5 and interferon-γ gene expression in steroid resistant asthma. J Exp Med. 1995;181:33-40.
41. Spahn J, Szefler SJ, Surs W, Doherty DE, Nimmagadda SR, Leung DY. A novel action of IL-13: induction of diminished monocyte glucocorticoid receptor-binding affinity. J Immunol. 1996;157:2654-2659.
42. Goleva E, Li L-B, Eves PT, Strand MJ, Martin RJ, Leung DYM. Increased glucocorticoid receptor-β alters steroid response in glucocorticoid- insensitive asthma. Am J Respir Crit Care Med. 2006;173: 07-616.
43. Ito K, Chung KF, Adcock IM. Update on glucocorticoid action on resistance. J Allergy Clin Immunol. 2006;117:522-543.
44. Barnes PJ. How corticosteroids control inflammation: Quintiles Prize Lecture 2005. Br J Pharmacol. 2006;148:245-254.
45. Adler A, Cieslewicz G, Irvin CG. Unrestrained plethysmography is an unreliable measure of airway responsiveness in BALBc and C57-BL/ mice. J Applied Physiol. 2004;97:286-292.
46. Lomask M. Further exploration of the Penh parameter. Exp Toxicol Pathol. 2006;57(suppl2):13-20.
47. Daines M, Chen W, Tabata Y, et al. Allergen-dependent solubilization of IL-13 receptor α2 reveals a novel mechanism to regulate allergy. J Allergy Clin Immunol. 2007;119:375-383.
48. Therien AG, Bernier B, Weicker S, et al. Adenovirus IL-13-induced airway disease in mice: a corticosteroid-resistant model of severe asthma. Am J Respir Cell Mol Biol. 2008;39:26-35.